Streptococcus bovis Q6 for producing feruloyl esterase, bacterial suspension, preparation method and application
By isolating and identifying the Q6 strain of Streptococcus bovine, the problem of difficulty in colonizing rumen in exogenous microorganisms is solved, efficient ferulic esterase production and feed digestibility improvement, and the digestive performance and rough feed utilization of animals are improved. Have antibacterial effects.
Patent Information
- Application Number
- CN202410951871.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-07-16
AI Technical Summary
In the prior art, exogenous microorganisms are difficult to colonize in the rumen of ruminants, resulting in low efficiency of ferulic acid esterase during feed digestion, limiting the digestibility of crude feed and animal production performance.
Isolate and identify a strain of Streptococcus bovine Q6 that can colonize in the rumen. This strain can produce ferulic acid esterase and improve its application in feed through specific bacterial suspension preparation methods and fermentation broth preparation processes. efficiency.
The possibility of colonizing Streptococcus bovine Q6 in the rumen is high, which can effectively improve the digestibility of feed, improve the digestibility of animals, and has antioxidant properties and antibacterial effects. It is suitable for improving the utilization rate of crude feed and preparing antibacterial agents.
Smart Images

Figure CN119060875A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of microbial application, and in particular to a strain of bovine streptococcus Q6 producing ferulic acid esterase, a bacterial suspension, a preparation method and an application thereof. Background Art
[0002] Roughage is an important feed source for ruminants, and improving the digestibility of roughage is of great significance to the production performance of ruminants. The digestible energy of forage depends largely on the digestibility of dry matter or fiber. Therefore, improving the quality and digestibility of roughage has always been an important issue of concern in animal husbandry.
[0003] Straw roughage has always been a commonly used raw material in animal husbandry, but because it contains a large amount of lignocellulose, it has certain limitations in the subsequent enzymatic digestion or rumen digestion process, which manifests as a low digestibility in ruminants and has an adverse effect on the production performance of ruminants.
[0004] Numerous studies have shown that phenolic substances in plant cell walls are the main factor inhibiting forage digestibility. Ferulic acid is one of the main phenolic components widely present in plant cell walls. It is mainly covalently cross-linked with polysaccharides in the cell wall by ester bonds, and covalently cross-linked with lignin components by ether bonds or lipid bonds to form ferulic acid ester bonds.
[0005] Existing methods to increase the digestibility of lignocellulose include physical and mechanical processing, chemical treatment and biological treatment. Mechanical processing is a key step in feed production because it affects the physical properties of the feed, making livestock feel full and limiting their feed intake. Many studies have reported the effects of mechanical processing on the particle size of dairy cow diets such as hay, straw or silage. Feed particle size is crucial in livestock diets because the feed must contain enough physically effective neutral detergent fiber, which can stimulate livestock to chew and secrete saliva, reduce gastrointestinal fullness, but do not reduce digestibility. Chemical treatment mainly directly destroys the structure of lignocellulose through chemical reactions. It is mainly divided into acid treatment and alkali treatment. Biological treatment includes the addition of exogenous enzymes and bacterial inoculation treatment.
[0006] Exogenous cellulase is applied to the fiber diet before feeding, and part of the neutral detergent fiber and acid detergent fiber are hydrolyzed and release sugars and free monomer hydroxycinnamic acid, which helps to improve the in vitro fiber digestibility. Ferulic acid esterase (FAE) has been used to improve the performance of exogenous cellulase in ruminant feed in recent years. When ferulic acid cross-links arabinoxylan and lignin through ester bonds and ether bonds, respectively, the digestion degree of lignocellulose will be significantly reduced. Esterase is a new enzyme required to hydrolyze ester bonds and release ferulic acid from the cell wall. It is generally produced by fungi and rarely exists in the rumen environment. For example, there are strains with high enzyme production efficiency such as molds or Bacillus in the prior art, but as exogenous microorganisms, it is difficult to colonize in the rumen. Therefore, it is of practical significance to separate and screen new microorganisms that can adapt to the rumen environment and produce ferulic acid esterase from the environment. Summary of the invention
[0007] In order to obtain a microorganism producing feruloyl esterase, the present invention provides a strain of bovine streptococcus Q6 producing feruloyl esterase, a bacterial suspension, a preparation method and an application thereof. The bovine streptococcus Q6 separated and obtained by the present invention has the characteristic of producing feruloyl esterase.
[0008] The present invention provides a strain of bovine streptococcus Q6 producing ferulic acid esterase. The bovine streptococcus Q6 was deposited in China Center for Type Culture Collection on January 29, 2024, and the deposit number is: CCTCC NO: M2024253.
[0009] The bovine Streptococcus Q6 is isolated from the rumen, so the possibility of colonization in the rumen is much higher than that of other exogenous strains. Therefore, it has great significance.
[0010] The present invention also provides a method for preparing a bacterial suspension, which comprises picking a single colony of bovine streptococcus Q6 and placing it in an MRS liquid culture medium, culturing it anaerobically at 37° C. to 38° C. for 12 h to 16 h, centrifuging it at 7000 r / min to 8000 r / min for 5 min to 10 min, collecting the bacterial bodies, washing them with sterile saline, and then resuspending them in deionized water to obtain a bacterial suspension.
[0011] Furthermore, the centrifugation condition is: 8000r / min for 5min.
[0012] The present invention also provides a bacterial suspension, which is prepared by the bacterial suspension preparation method.
[0013] The invention also provides a fermentation liquid obtained by fermenting the bacterial suspension.
[0014] The present invention also provides a method for preparing the fermentation liquid, wherein the bacterial suspension is inoculated into a liquid fermentation enzyme production medium at an inoculation rate of 2% to 3%, and anaerobically fermented at 37° C. to 38° C. for 2 days to 2.5 days to obtain the fermentation liquid;
[0015] The liquid fermentation enzyme production medium is: 10g peptone, 10g beef extract, 5g yeast extract, 5g anhydrous sodium acetate, 2g diammonium hydrogen citrate, 2g dipotassium hydrogen phosphate, 0.58g magnesium sulfate, 0.17g manganese sulfate, 1mL Tween-80, 14g agar, 50mL methyl ferulate solution, and 1L distilled water;
[0016] The methyl ferulate solution is prepared by dissolving methyl ferulate in dimethylformamide at a mass volume ratio of 1%.
[0017] Furthermore, the inoculation amount of the bacterial suspension is 2% to 3%, and the fermentation condition is anaerobic fermentation at 37° C. to 38° C. for 2 days.
[0018] Furthermore, the inoculation amount of the bacterial suspension is 2%, and the fermentation condition is anaerobic fermentation at 37° C. for 2 days.
[0019] The present invention also provides a method for producing ferulic acid esterase, comprising the steps of centrifuging the bovine streptococcus Q6 culture and resuspending the culture in deionized water to obtain a bacterial suspension, then inoculating the bacterial suspension into a liquid fermentation enzyme production medium for anaerobic fermentation to obtain a fermentation liquid, and centrifuging and obtaining a supernatant as a crude enzyme liquid.
[0020] The present invention also provides an application of the feruloyl esterase-producing bovine streptococcus Q6, the bacterial suspension or the fermentation liquid in the preparation of feruloyl esterase.
[0021] The present invention also provides an application of the ferulic acid esterase-producing bovine streptococcus Q6, the bacterial suspension or the fermentation broth in inhibiting pathogenic bacteria, wherein the pathogenic bacteria is any one or more combinations of Escherichia coli E. coli, Salmonella pullorum S. pullorum and Staphylococcus aureus S. aureus.
[0022] Compared with the prior art, the present invention has the following beneficial effects:
[0023] 1. The present invention separates and screens a bovine streptococcus Q6, with a deposit number of CCTCC NO: M2024254. A transparent zone appears when cultured on a solid plate, and the diameter of the transparent zone is 18.09±1.01 mm. It is found through detection that the transparent zone is the produced feruloyl esterase. A crude enzyme liquid is obtained by fermenting bovine streptococcus Q6, and the detection shows that the feruloyl esterase activity is 1.53±0.06 mU / mL.
[0024] The bovine streptococcus Q6 isolated and obtained by the present invention is isolated from the rumen, so the possibility of colonization in the rumen is much higher than that of other exogenous strains. The ferulic acid esterase produced by the streptococcus Q6 acts on the ingested feed, and can regulate the intestine and promote digestion.
[0025] 2. Streptococcus bovis Q6 has the function of producing ferulic acid esterase. Therefore, the ferulic acid esterase produced by the bacteria can be used to ferment agricultural waste, such as straw, to obtain ferulic acid in the agricultural waste. Ferulic acid has antioxidant properties and can be used in the manufacture of cosmetics, health care products and other products.
[0026] 3. The bovine Streptococcus Q6 can also effectively inhibit the growth of Escherichia coli E. coli, Salmonella pullorum S. pullorum and Staphylococcus aureus S. aureus, and has the potential to prepare antibacterial agents.
[0027] 4. According to the structural characteristics of lignocellulose in plant cell walls, ferulic acid esterase can break the ferulic acid ester bond therein, thereby destroying the cell wall, thereby improving the digestibility of ruminants and achieving the purpose of efficient use of roughage. Therefore, the bovine Streptococcus Q6 of the present invention can be applied in the following two ways:
[0028] ① Spray the strain on roughage (such as straw), create an anaerobic environment through sealing and other means, and ferment for a certain period of time so that the strain can improve the feed quality and increase the utilization rate of roughage by animals through the dual characteristics of lactobacillus and ferulic acid esterase.
[0029] ② Feed the strain directly to animals to take advantage of its isolation from the rumen, allowing it to colonize in the rumen and produce effects in the rumen to increase the animal's digestibility and improve rumen health.
[0030] Information on the deposit of biological materials
[0031] Q6, referred to as Streptococcus bovis Q6 in this application, has been deposited in the China Center for Type Culture Collection on January 29, 2024, with the deposit number: CCTCC NO: M 2024253. The address of the depository is Wuhan University, Wuhan, China, Postal Code: 430072, and the classification name is: Streptococcus boviae Q6. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0033] Figure 1 This is a streak plate image of strain Q6 in the present invention.
[0034] Figure 2It is the Oxford cup transparent circle of the strain Q6 in the present invention in the culture dish.
[0035] Figure 3 This is the growth curve of strain Q6 in the present invention.
[0036] Figure 4 The inhibitory effect of strain Q6 of the present invention on different pathogens;
[0037] In the figure, a, b, and c are the antibacterial effects of Q6 strain on E. coli, and a, b, and c are three parallel experiments;
[0038] d, e, and f are the antibacterial effects of Q6 strain on Salmonella pullorum S. pullorum, and d, e, and f are three parallel experiments;
[0039] g, h, and i are the antibacterial effects of Q6 strain on Staphylococcus aureus S. aureus. g, h, and i are three parallel experiments. DETAILED DESCRIPTION
[0040] The specific embodiments of the present invention are described in detail below, but it should be understood that the protection scope of the present invention is not limited by the specific embodiments. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention. The experimental methods described in the embodiments of the present invention are conventional methods unless otherwise specified, and the materials, reagents, etc. used in the following embodiments can be obtained from commercial channels unless otherwise specified.
[0041] Example 1: Isolation, screening and identification of a ferulic acid esterase-producing Lactobacillus mucosa strain.
[0042] 1. Experimental Materials and Methods
[0043] 1. Samples and culture media
[0044] (1) MRS liquid medium: 20 g glucose, 10 g peptone, 10 g beef extract, 5 g yeast extract, 5 g anhydrous sodium acetate, 2 g diammonium hydrogen citrate, 2 g dipotassium hydrogen phosphate, 0.58 g magnesium sulfate, 0.17 g manganese sulfate, 1 mL Tween-80, and 1 L distilled water.
[0045] MRS solid medium: glucose 20g, peptone 10g, beef extract 10g, yeast extract 5g, anhydrous sodium acetate 5g, diammonium hydrogen citrate 2g, dipotassium hydrogen phosphate 2g, magnesium sulfate 0.58g, manganese sulfate 0.17g, Tween-80 1mL, agar 14g, distilled water 1L.
[0046] (2) Screening medium: Sterilize MRS solid medium without adding glucose, cool to about 60°C, add 15 mL / L of ethyl ferulate solution that has been sterilized by filtration, and shake well immediately.
[0047] Liquid fermentation enzyme production medium: MRS medium without glucose, sterilized and cooled to about 60℃, and 50mL / L methyl ferulate solution was added;
[0048] The methyl ferulate solution is prepared by dissolving methyl ferulate in dimethylformamide at a mass volume ratio of 1%.
[0049] Preparation of ethyl ferulate solution: dissolve ethyl ferulate in dimethylformamide at a mass volume ratio of 10%, and filter and sterilize to obtain the solution.
[0050] (3) Rumen fluid was collected from adult Kazakh rams, frozen at −20°C, and brought back to the laboratory.
[0051] 2. Preliminary screening of ferulic acid esterase producing strains
[0052] The rumen fluid thawed at room temperature was inoculated into MRS liquid culture medium at an inoculum rate of 1%, and cultured anaerobically at 37°C for 12 h. Then, the screening culture medium was inoculated by the cross-streaking method, and cultured at 37°C for 72 h. The streaking inoculation was repeated until a transparent phenomenon, such as a transparent zone or a transparent circle, appeared. It can be preliminarily considered that a strain producing ferulic acid esterase has been obtained.
[0053] 3. Rescreening of ferulic acid esterase producing strains
[0054] Plate transparent circle: After the strains obtained in the initial screening are inoculated and streaked on MRS solid medium, the bacterial colonies that appear transparent are dipped into the screening medium with an inoculation needle, cultured at 37°C for 72 hours, and then observed whether transparent circles appear on the plate. The bacterial colonies that produce transparent circles can be preliminarily determined to produce feruloyl esterase, which is abbreviated as FAE.
[0055] Oxford cup transparent zone: For strains that produce transparent zones, to further determine the relationship between enzyme activity and transparent zone size. After the strains are cultured overnight in MRS liquid medium, centrifuge at 8000r / min for 5 minutes to collect the bacteria. Wash the bacteria three times with sterile saline and resuspend in deionized water. Place an Oxford cup on the screening medium, collect 200μL of the solution and resuspend in deionized water to obtain a resuspended solution, and culture anaerobically for 3 days. Observe the size of the transparent zone.
[0056] 4. Save
[0057] Select a single colony that can produce a transparent circle on the screening medium, purify it for more than three generations, pick a single colony with stable characteristics and put it into MRS liquid medium, culture it anaerobically at 37℃, and OD 600Preserve bacteria at 0.6-0.8% glycerol and store at -80℃.
[0058] 5. Main biochemical reactions
[0059] Inoculate a loopful of the resuspension into a bacterial microbiochemical reaction tube, culture at 37°C for 2 to 3 days, and then observe the color change.
[0060] 6. Determination of strain growth curve
[0061] The growth curve of the strain was determined using the Ningbo Xinzhi MGC-200 microbial growth curve analyzer. The 96-well plate was sealed in an anaerobic environment, 200uL of culture medium was added to each well, 2.5uL of bacterial solution was inoculated, and cultured at 37°C for 48h.
[0062] 7. Determination of ferulic acid esterase activity
[0063] (1) Preparation of crude enzyme solution
[0064] Culture the strain overnight (pick a single colony and inoculate it into MRS liquid medium, 37°C, 12h, anaerobic culture), centrifuge at 8000r / min for 5min, and collect the bacteria. Wash the bacteria 3 times with sterile saline, resuspend in deionized water, and obtain a bacterial suspension. Inoculate the bacterial suspension (2% inoculation amount) into the liquid fermentation enzyme production medium, and obtain the fermentation liquid by anaerobic fermentation at 37°C for 2d. Centrifuge the fermentation liquid at 8000r / min for 5min, and take the supernatant to obtain the crude enzyme liquid.
[0065] (2) Calculation of enzyme activity
[0066] The invention patent of Yang Hongjian, "A method for detecting ferulic acid esterase activity", was used with slight modifications. 100uL of crude enzyme solution diluted 6.25 times was added to a 96-well plate and preheated at 39°C for 15 minutes. 200uL of preheated ferulic acid methyl ester solution was added to the blank group, and 200uL of MOPS (100mM) was added to the reaction group. The reaction was carried out at 39°C for 30 minutes. The OD was measured by an enzyme reader before and after the reaction. 340 .
[0067] Calculated according to the following formula:
[0068]
[0069] The meanings of the parameters are:
[0070] OD 反应起始 : OD value at the start of the reaction;
[0071] OD 反应终止 : OD value at which the reaction was terminated;
[0072] OD 空白起始 : OD value at the start of the reaction without enzyme addition;
[0073] OD 空白终止 : OD value at which the reaction is terminated without adding enzyme;
[0074] V 体系 =300μL; l ε阿魏酸甲酯 =9.467L / mM; l ε阿魏酸 =2.049L / mM; V 样品 =100 μL;
[0075] Sample dilution factor = 6.25; reaction time = 30 min.
[0076] 8. Identification
[0077] The strain stored at -80°C was thawed at room temperature and inoculated into MRS liquid culture medium at 1% inoculation volume and cultured anaerobically at 37°C for 12 h. The strain was extracted and stored in a 1.5 mL centrifuge tube and sent to Shanghai Sangon Biotechnology Co., Ltd. for 16S rDNA full sequence analysis.
[0078] 9. Oxford cup antibacterial test
[0079] (1) Preparation of indicator bacteria suspension:
[0080] Escherichia coli, Salmonella pullorum, and Staphylococcus aureus were used as indicator bacteria. The strains were preserved in the Feed Biotechnology Research Laboratory, College of Animal Science, Xinjiang Agricultural University. The pathogenic bacteria were activated and cultured twice using LB medium. A single colony was picked and cultured in LB liquid medium at 37°C and 170 r / min at a concentration of 10 8 CFU / mL, the indicator bacteria suspension was obtained.
[0081] (2) Determination of antibacterial activity
[0082] A single colony of S. bovis Q6 producing a transparent circle was inoculated into MRS liquid medium and cultured until 10 8 CFU / mL, 200 μL of bacterial solution was placed in an Oxford cup, and the diameter of the inhibition zone was measured using ProtoCOL3P3HD / 1129 produced by SYNBIOSIS Integrated Technology Co., Ltd. in the UK. The diameter of the inhibition zone of the Oxford cup was recorded, and the diameter of the inhibition zone was obtained by subtracting 8 mm from the Oxford cup.
[0083] 2. Experimental Results
[0084] 1. Flat plate streaking screening results
[0085] The MRS liquid medium cultured overnight was streaked onto the screening medium. A strain that could produce transparency was found on the screening medium and was recorded as Q6. The streaked culture plate was as follows: Figure 1shown.
[0086] 2. Oxford Cup Transparent Circle Screening Results
[0087] The size of the transparent zone produced by strain Q6 was further determined by the Oxford cup transparent zone test. The transparent zone produced after dark culture was as follows: Figure 2 shown.
[0088] Record the diameter of the transparent ring of the Oxford cup (minus the diameter of the Oxford cup). The results are shown in Table 1.
[0089] Table 1 Size of Oxford cup transparent zone produced by strains
[0090]
[0091] 3. Main biochemical reactions of strains
[0092] Table 2 Main biochemical reactions
[0093]
[0094] Note: “+” indicates a positive reaction, and “-” indicates a negative reaction.
[0095] As shown in Table 2, with reference to GB4789.35-2023, strain Q6 showed positive reactions to esculin, maltose, salicin, sorbitol, sucrose, raffinose inulin, and lactose, and negative reactions to mannitol and sodium hippurate. Among them, the positive esculin test indicated that the strain belonged to group D streptococcus, which was consistent with the result of strain identification.
[0096] 4. Determination of strain growth curve
[0097] like Figure 3 As shown, during the 0-2h cultivation, strain Q6 grew slowly and was in a stagnant period; during the 2-13h cultivation, it entered a logarithmic growth phase with the fastest growth rate; after 13h of cultivation, the growth of the strain entered a plateau period and gradually stabilized.
[0098] 5. Determination of ferulic acid esterase crude enzyme activity
[0099] According to the determination by the microplate reader, the feruloyl esterase activity of the feruloyl esterase-producing strain Q6 was calculated using the formula, and the results are shown in Table 3. The feruloyl esterase activity of the strain Q6 was 1.53±0.06 mU / mL.
[0100] Table 3 Ferulic acid esterase activity of strains
[0101] Strain number Enzyme activity (mU / mL) Q6 1.53±0.06
[0102] 6. Strain sequence comparison results
[0103] The sequence comparison results show that the strain Q6 has a 100% similarity to Streptococcus bovis PP916666 in Genbank. Therefore, the strain Q6 is identified as Streptococcus bovis.
[0104] 7. Inhibition of bovine Streptococcus Q6 on pathogens
[0105] Table 4 Size of inhibition zone produced by Q6 strain
[0106] Indicator strain Diameter of inhibition zone (mm) E. coli 7.37±0.66 Salmonella pullorum 6.48±0.97 Staphylococcus aureus 9.91±0.64
[0107] The results are shown in Table 4 and Figure 4 As shown in the figure, in terms of antibacterial effect, Streptococcus bovis Q6 showed an inhibitory effect on Escherichia coli, Salmonella pullorum and Staphylococcus aureus. The antibacterial effect on Staphylococcus aureus was the most obvious.
[0108] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.
[0109] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A strain of Streptococcus bovis Q6 producing ferulic acid esterase, It is characterized in that The bovine Streptococcus Q6 was deposited in the China Center for Type Culture Collection on January 29, 2024, with the deposit number: CCTCC NO: M2024253.
2. A method for preparing a bacterial suspension, It is characterized in that Pick a single colony of the bovine Streptococcus Q6 described in claim 1 into an MRS liquid culture medium, culture it anaerobically at 37° C. to 38° C. for 12 h to 16 h, centrifuge it at 7000 r / min to 8000 r / min for 5 min to 10 min, collect the bacteria, wash them with sterile saline, and then resuspend them in deionized water to obtain a bacterial suspension.
3. The method for preparing the bacterial suspension according to claim 2, It is characterized in that The centrifugal conditions were: 8000 r / min for 5 min.
4. A bacterial suspension, It is characterized in that The bacterial suspension is prepared by the method for preparing the bacterial suspension according to claim 2 or 3.
5. A fermentation liquid, It is characterized in that Obtained by fermenting the bacterial suspension according to claim 4.
6. A method for preparing the fermentation liquid according to claim 5, It is characterized in that Inoculate the bacterial suspension into a liquid fermentation enzyme production medium at an inoculation rate of 2% to 3%, and perform anaerobically fermentation at 37° C. to 38° C. for 2 days to 2.5 days to obtain a fermentation liquid; The liquid fermentation enzyme production medium is: 10g peptone, 10g beef extract, 5g yeast extract, 5g anhydrous sodium acetate, 2g diammonium hydrogen citrate, 2g dipotassium hydrogen phosphate, 0.58g magnesium sulfate, 0.17g manganese sulfate, 1mL Tween-80, 14g agar, 50mL methyl ferulate solution, and 1L distilled water; The methyl ferulate solution is prepared by dissolving methyl ferulate in dimethylformamide at a mass volume ratio of 1%.
7. The method for preparing the fermentation liquid according to claim 6, It is characterized in that The inoculation amount of the bacterial suspension is 2% to 3%, and the fermentation condition is anaerobic fermentation at 37° C. to 38° C. for 2 days.
8. A method for producing ferulic acid esterase, It is characterized in that The bovine Streptococcus Q6 culture of claim 1 is centrifuged and resuspended with deionized water to obtain a bacterial suspension, and then the bacterial suspension is inoculated into a liquid fermentation enzyme production medium for anaerobic fermentation to obtain a fermentation liquid, and the supernatant is obtained as a crude enzyme liquid after centrifugation.
9. Use of the ferulic acid esterase-producing bovine Streptococcus Q6 according to claim 1, the bacterial suspension according to claim 4 or the fermentation broth according to claim 5 in the preparation of ferulic acid esterase.
10. Use of the ferulic acid esterase-producing bovine Streptococcus Q6 according to claim 1, the bacterial suspension according to claim 4 or the fermentation liquid according to claim 5 in inhibiting pathogenic bacteria, It is characterized in that The pathogenic bacteria is any one or more of Escherichia coli, Salmonella pullorum and Staphylococcus aureus.
Citation Information
Patent Citations
Two strains for producing feruloyl esterase
CN116731898A
Isolation, identification and application of streptococcus sp. 121
US20220339209A1
